Immunovant Inc
(NAS:IMVT)
$
42.03
-0.57 (-1.34%)
Market Cap: 8.68 Bil
Enterprise Value: 7.78 Bil
PE Ratio: 0
PB Ratio: 11.77
GF Score: 29/100 Immunovant Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 12, 2020 / 03:15PM GMT
Release Date Price:
$49.14
(+0.02%)
Tiago Felipe Fauth;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
Everyone, welcome to the last day of our healthcare conference at Crédit Suisse. My name is Tiago Fauth, mid-cap biotech analyst here at Crédit Suisse. And I'm joined today by the Immunovant team. They're going to do a presentation. Feel free to e-mail me any questions, and I'll try to work those in towards the end.
But for now, that's it, I think. Pete, you can take it away.
Peter Salzmann
Immunovant, Inc. - CEO & Director
Super. Thanks, Tiago. Let me just share my screen here. You see that, okay?
Tiago Felipe Fauth;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
Yes.
Peter Salzmann
Immunovant, Inc. - CEO & Director
Excellent. So I just want to briefly touch on our safe harbor presentation statement. This is on our website, this entire presentation is on our website, and I will be making some forward-looking
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot